MetaVia Inc. Common Stock (MTVA) is a publicly traded Healthcare sector company. As of October 13, 2026, MTVA trades at $1.49 with a market cap of $9.29M and a P/E ratio of -0.18. MTVA moved +0.00% today. Year to date, MTVA is -82.78%; over the trailing twelve months it is -86.52%. Its 52-week range spans $0.97 to $23.10. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces MTVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover MTVA: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $14.00.
| Metric | Value |
|---|---|
| Price | $1.49 |
| Market Cap | $9.29M |
| P/E Ratio | -0.18 |
| EPS | $-7.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.10 |
| 52-Week Low | $0.97 |
| Volume | 20.62K |
| Avg Volume | 0 |
| Revenue (TTM) | $510.00K |
| Net Income | $-12.97M |
| Gross Margin | 0.00% |
2 analysts cover MTVA: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.